"In India, people generally suffer from various hyperpigmentary disorders such as melasma and post- inflammatory hyperpigmentation (PIH) that result in an uneven skin tone," Galderma India Managing Director, G Sathya Narayanan said in a statement.
He further said: "...We are confident that our latest product will emerge as an effective dermatological solution for patients suffering from hyperpigmentary disorders and restore their skin with an even tone and glow".
The product contains natural skin lightening ingredients, along with UVB filter and anti-oxidants, the company said.
As per IMS data, India's hyperpigmentation market is valued at Rs 391 crore and is growing at 19 per cent year-on-year.